Filing Details
Sarasin & Partners LLP, a registered investment adviser, increased its position in CME Group Inc. (NASDAQ:CME) by 41.2% during Q2 2026, according to its most recent 13F filing with the Securities and Exchange Commission.
The firm purchased an additional 383,581 shares of the Financial Services company, bringing its total holdings to 1,314,268 shares valued at approximately $290.2M as of the filing date.
Market Context
CME Group Inc.'s stock currently trades at $246.00 with a market capitalization of $98.2B.
An increase in an existing position suggests Sarasin & Partners LLP has growing conviction in CME Group Inc.'s trajectory. Institutional investors typically add to positions when they believe the stock still has upside relative to their price target, or when the company's fundamentals have improved since their initial purchase.
Financial sector holdings are closely tied to interest rate expectations and economic outlook. Institutional moves in CME Group Inc. may reflect broader views on credit conditions and banking sector profitability.
The size of this position — $290.2 million — places it among the more significant institutional holdings in CME Group Inc.. Large positions like this can influence trading dynamics and are closely watched by market participants tracking smart money flows.
Investors should note that 13F filings reflect holdings as of the end of the reporting quarter and are filed up to 45 days later. The position may have changed since the filing date. 13F data is most useful when analyzed alongside other signals such as insider transactions, analyst ratings, and fundamental trends.
Related Tools: Insider Trades Tracker | View CME Stock Page
Frequently Asked Questions
What is a 13F filing?
A 13F filing is a quarterly SEC report required for institutional managers with over $100 million in assets. It discloses equity holdings, providing transparency into how firms like Sarasin & Partners LLP position their portfolios.
How can I track institutional ownership of CME?
View all institutional holders on our CME institutional ownership page.